Diversified firm SRF, on Thursday, announced the acquisition of U.S.-based DuPont’s pharmaceutical propellant business under the Dymel brand for $20 million (over Rs.120 crore) in an all-cash deal. The company has signed a definitive agreement with E I DuPont De Nemours and Company USA for the transaction, SRF said in a filing to the BSE. — PTI